Learning Objectives:

1. Identify risk factors, importance of surveillance and diagnosis of HCC

2. Highlight updates on systemic and locoregional therapy in HCC

3. Highlight key treatment options for early, intermediate and advanced HCC

Session date: 
06/23/2021 - 5:00pm to 6:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anjana Pillai, MD; Shih-Yi "Andy" Liao, MD; Osman Ahmed, MD